Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
about
Wnt Signaling in Cancer Stem Cell BiologyBrain tumor stem cells: Molecular characteristics and their impact on therapyCSNK1A1 and Gli2 as Novel Targets Identified Through an Integrative Analysis of Gene Expression Data, Protein-Protein Interaction and Pathways Networks in Glioblastoma Tumors: Can These Two Be Antagonistic Proteins?Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR GammaTumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways.Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation via β-catenin signaling.Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progressionWnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathwayGenomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.HOTAIR is a therapeutic target in glioblastoma.Wnt3a: functions and implications in cancer.Wnt3a Mediates the Inhibitory Effect of Hyperoxia on the Transdifferentiation of AECIIs to AECIs.Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system diseaseAdult neurogenesis and glial oncogenesis: when the process fails.Mechanisms regulating glioma invasion.Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.Long non-coding RNA in glioma: signaling pathways.Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal GlioblastomaTranscriptomic study of mouse embryonic neural stem cell differentiation under ethanol treatment.Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers.Expression profile and clinical significance of Wnt signaling in human gliomas.Intranasally Delivered Wnt3a Improves Functional Recovery after Traumatic Brain Injury by Modulating Autophagic, Apoptotic and Regenerative Pathways in the Mouse Brain.Signaling pathways and mesenchymal transition in pediatric high-grade glioma.Wnt3a expression is associated with poor prognosis of esophageal squamous cell carcinoma.Multiple oncogenic roles of nuclear beta-catenin.Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication.Wls promotes the proliferation of breast cancer cells via Wnt signaling.Salinomycin-loaded Nanofibers for Glioblastoma Therapy.Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.is a novel oncogenic prognostic biomarker in human glioblastomaMicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular CarcinomaCasein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival
P2860
Q26746101-2EF0E546-2A86-4152-8EFC-152D9FBB9607Q27003138-1605BAC7-39D8-463A-A4BA-CA4A3A99CF10Q30867941-B6BCB0BC-EAB8-4D21-9284-CC219E575D05Q33748280-43B89ECD-A230-4D6D-B52E-6972BB40BFA8Q33764768-9F1B5AFB-732A-4F6D-849C-8292F53A12A3Q34414641-4FA29F7C-B360-4C4E-BB91-9F39DE778943Q34728041-3D469044-14D4-4662-A412-DC61F278AE66Q35067970-5E26F78A-8620-4449-94E3-C8ABE38375C0Q35562809-D53DF410-C338-4F97-8CFD-6FD98F53EF4DQ35781595-88B7C31E-C909-4631-864D-0DB7154196C8Q36121065-5D5A5CC6-B750-4E7E-B334-AF60C45BACF6Q36742578-D0C85D85-FAEB-4B95-A3BA-5207FCF79A3CQ36747844-7844F422-86B0-412D-B8C7-F8694F197FD2Q36795811-FFC2EC70-85F5-4A1D-A6E3-2D36FDE17524Q37024249-8D10A924-808A-4BA2-AD1B-475176C462D5Q37187706-A44AC839-BDDE-416F-AB37-446D4151B330Q38124430-5D22B927-BDA4-43B4-9CD2-ED70A0396E65Q38204976-F21DB0A8-8FCC-4712-956E-27EB4393C62AQ38386429-86A27A03-FA4E-4DDC-89CF-132AE4E5464EQ38775522-2BD3E3DB-78D7-45D4-9C60-9DBBB38E0524Q38848185-6CA12984-827A-4AB3-95B8-D73411FA2CB5Q39130527-20B03C09-D09E-46AF-98C2-42947F1753D5Q39404706-59175067-30EF-4478-8F02-F2E597EFCD57Q40311544-31DF1FD4-3BE0-47B2-917E-4C2169233A25Q40974703-96BED65C-567A-47A0-A10C-9693229D85AAQ41388752-9CD74D7B-019C-4C7B-A5B2-CD19A0333DEDQ47219767-E668902E-1DF0-4ABC-A37C-38BE70DF805DQ47827635-D038D3BC-CDEB-4C34-92DF-23A88996C7BFQ47983763-9570C4A8-4914-4825-B8D4-4414417FD439Q48258004-9AB73D5A-E9B9-4B60-9D33-CF95809AB12CQ49430709-17E71A16-A008-4D78-9FD3-3E57D07D3453Q49919956-04A53AE3-9218-4FFF-BF83-00B441BE8EFFQ50054057-FF495C33-D6C0-4AB7-92E9-8DC0244D5F1CQ53568356-3092E38F-6F3A-4D30-B333-249377F1C13CQ55429325-6A2A9E76-FE38-4A02-9EAC-D7266B0BD88DQ55457391-63055557-202F-4C52-8A01-7F3555C37D39Q57116044-8BE95045-7CAD-457A-87CE-682D906D152CQ58700017-646A375D-DBE2-4B59-BA8C-DF5DAF62D454Q58751776-B9C8AE8B-B2CC-4122-99E8-384AA6E0EB45
P2860
Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Wnt3a mediated activation of W ...... r progression in glioblastoma.
@en
Wnt3a mediated activation of W ...... r progression in glioblastoma.
@nl
type
label
Wnt3a mediated activation of W ...... r progression in glioblastoma.
@en
Wnt3a mediated activation of W ...... r progression in glioblastoma.
@nl
prefLabel
Wnt3a mediated activation of W ...... r progression in glioblastoma.
@en
Wnt3a mediated activation of W ...... r progression in glioblastoma.
@nl
P2093
P1476
Wnt3a mediated activation of W ...... r progression in glioblastoma.
@en
P2093
Anjali Shiras
Dattatraya Muzumdar
M L Shaikh
Navjot Kaur
Phalguni Rath
Sachin Rathod
Sivarajan Chettiar
P356
10.1016/J.MCN.2013.01.001
P577
2013-01-19T00:00:00Z